Direct and indirect costs of infectious conjunctivitis in a commercially insured population in the United States
Clinical Ophthalmology Feb 16, 2020
Pepose JS, Sarda SP, Cheng WY, et al. - Researchers conducted the study for analyzing the direct and indirect costs of infectious conjunctivitis and quantify medical costs due to conjunctivitis transmission in families. Beneficiaries with or without at least one diagnosis of infectious conjunctivitis were identified in this retrospective claims analysis from the OptumHealth Care Solutions, Inc. database (1998– 2016). Using cost differences in linear regressions, direct and indirect costs (in 2016 US$) during the 60 days post conjunctivitis diagnosis (or imputed date for controls) were contrasted. The authors discovered that healthcare resource utilization and direct costs were significantly higher for patients with conjunctivitis (n = 1,002,188) compared with controls (n = 4,877,210). Data reported that the cost of medically related absenteeism was $105.42 higher for patients with conjunctivitis than for controls. Findings suggested an association of conjunctivitis with a notable economic burden in terms of direct medical costs and medically related absenteeism. With transmission time, the cost of family healthcare increased, and with each family member infected with conjunctivitis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries